- Home
- SGRP vs BOLD Comparison
SGRP vs BOLD Comparison
Compare SGRP & BOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- BOLD
- Stock Information
- Founded
- SGRP 1967
- BOLD 2018
- Country
- SGRP United States
- BOLD United States
- Employees
- SGRP N/A
- BOLD N/A
- Industry
- SGRP Business Services
- BOLD
- Sector
- SGRP Consumer Discretionary
- BOLD
- Exchange
- SGRP Nasdaq
- BOLD Nasdaq
- Market Cap
- SGRP 25.8M
- BOLD 24.4M
- IPO Year
- SGRP 1996
- BOLD 2024
- Fundamental
- Price
- SGRP $1.13
- BOLD $1.16
- Analyst Decision
- SGRP
- BOLD Buy
- Analyst Count
- SGRP 0
- BOLD 4
- Target Price
- SGRP N/A
- BOLD $4.00
- AVG Volume (30 Days)
- SGRP 66.2K
- BOLD 81.7K
- Earning Date
- SGRP 08-14-2025
- BOLD 08-05-2025
- Dividend Yield
- SGRP N/A
- BOLD N/A
- EPS Growth
- SGRP N/A
- BOLD N/A
- EPS
- SGRP N/A
- BOLD N/A
- Revenue
- SGRP $143,501,000.00
- BOLD N/A
- Revenue This Year
- SGRP $7.22
- BOLD N/A
- Revenue Next Year
- SGRP N/A
- BOLD N/A
- P/E Ratio
- SGRP N/A
- BOLD N/A
- Revenue Growth
- SGRP N/A
- BOLD N/A
- 52 Week Low
- SGRP $0.91
- BOLD $1.00
- 52 Week High
- SGRP $2.48
- BOLD $4.72
- Technical
- Relative Strength Index (RSI)
- SGRP 53.62
- BOLD N/A
- Support Level
- SGRP $1.05
- BOLD N/A
- Resistance Level
- SGRP $1.22
- BOLD N/A
- Average True Range (ATR)
- SGRP 0.06
- BOLD 0.00
- MACD
- SGRP -0.00
- BOLD 0.00
- Stochastic Oscillator
- SGRP 47.06
- BOLD 0.00
About SGRP SPAR Group Inc.
SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.
About BOLD Boundless Bio Inc. Common Stock
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.